CLS Holdings USA Inc. Reports Fiscal Year 2024 Third Quarter Performance and Provides Comprehensive Industry Outlook

In This Article:

Las Vegas, Nevada--(Newsfile Corp. - April 15, 2024) - CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH), the ''Company'' or ''CLS,'' a diversified cannabis company operating as Cannabis Life Sciences, today announced its financial results for the quarter ending February 29, 2024, and provided a detailed industry analysis in a statement from Chairman and CEO, Andrew Glashow.

CEO Andrew Glashow Shares Insights on Industry and Legislative Hurdles

In a detailed statement to shareholders, Glashow discussed the persistent challenges faced by the cannabis industry, primarily attributed to the absence of substantial federal legislative changes. He highlighted the company's efforts to navigate these challenges through strategic adjustments and operational improvements.

Industry and Legislative Outlook

Mr. Glashow provided a critical view of the cannabis industry's standing in political circles, emphasizing the need for federal reforms to address taxation and banking issues that continue to constrain the sector's growth. He acknowledged improvements at the state level, particularly in Nevada, where regulatory advancements have benefited the industry. However, he maintained a cautious stance on the likelihood of significant federal progress in the near term, suggesting that meaningful change might ultimately arise from Supreme Court action in 2025.

Key Points from Fiscal Q3 2024

  • Revenue: The company reported a revenue decrease to $4,926,457, marking a 9.4% dip from the previous year, attributed to broader economic challenges affecting the market.

  • Operational Developments: CLS Holdings underscored progress in its consumption lounge project in Nevada and its expansion into New Mexico and New York, leveraging licensing agreements for its City Trees brand.

  • Financial Health: Despite a challenging quarter, the company achieved positive net cash flow from operating activities of $588,850, for the nine months ending February 29, 2024, reflecting a 158% improvement compared to the same period of the prior year with a negative cash flow of $1,018,583. Along with this improvement, the company has also decreased its total liabilities by $3.2 million compared to the fiscal year end of May 31, 2023.

  • Market Position: The company's market capitalization stood at approximately $4 million, with an enterprise value of $11 million. CLS Holdings remains focused on evaluating opportunities to enhance shareholder value.

Looking Forward

Mr. Glashow reiterated the company's commitment to transparency and active communication with stakeholders, emphasizing the importance of adapting to industry dynamics and regulatory changes.